Literature DB >> 9069108

Anaerobic cocci of clinical importance.

M W Wren1.   

Abstract

The current knowledge is reviewed concerning the anaerobic cocci, in particular those of clinical relevance. The anaerobic cocci are defined and their current taxonomic positions discussed. It is clear that new genera and species await to be characterised fully. The overwhelming majority found in clinical material belong to the genus Peptostreptococcus, with the remainder belonging to the veillonellae and, possibly, ruminococci. Human infections with other anaerobic cocci are extremely rare. Their morphology, metabolism and culture, and role in clinical infections are assessed. The methods for isolation and identification, which for some species are difficult, are presented, together with brief summaries of the clinically important species. The review concludes with the current status of antibiotic susceptibilities and the methods used to test susceptibility in vitro. There is no current consensus as to which susceptibility test method is the method of choice.

Entities:  

Mesh:

Year:  1996        PMID: 9069108

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  4 in total

1.  Antimicrobial susceptibility of clinically relevant Gram-positive anaerobic cocci collected over a three-year period in the Netherlands.

Authors:  A C M Veloo; G W Welling; J E Degener
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

2.  Septic arthritis of knee joint due to Parvimonas micra.

Authors:  Moni Roy; Ashish Kumar Roy; Sharjeel Ahmad
Journal:  BMJ Case Rep       Date:  2017-11-14

3.  Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources.

Authors:  Eija Könönen; Anne Bryk; Päivi Niemi; Arja Kanervo-Nordström
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

Review 4.  Gram-positive anaerobic cocci.

Authors:  D A Murdoch
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.